Pulmonary Drug Delivery Devices Market Forecast Assessing Growth Potential And Industry Direction
The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Will Be The Estimated Market Size Of The Pulmonary Drug Delivery Devices Market By 2030?
The market size for pulmonary drug delivery devices has experienced robust growth in recent years. It is projected to expand from $52.8 billion in 2025 to $56.49 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.0%. Historically, this growth has been driven by factors such as the increasing incidence of respiratory ailments, the expanded adoption of inhalation therapies, the broadening of asthma and COPD treatment initiatives, advancements in inhaler design technologies, and enhanced public understanding of pulmonary drug delivery.
The pulmonary drug delivery devices market size is anticipated to undergo significant expansion in the coming years. It is projected to reach $71.9 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.2%. The expansion during the forecast period can be attributed to several factors, including the increasing demand for personalized respiratory therapies, the rising adoption of digital health-integrated inhalers, the broadening of home-based respiratory care, a heightened focus on non-invasive drug delivery, and ongoing innovation in inhalation technologies. Key trends during this period are expected to include the increasing adoption of smart and connected inhaler devices, a rising demand for targeted pulmonary drug delivery, the growing use of mesh and ultrasonic nebulizers, the expansion of combination drug-device products, and an enhanced focus on patient adherence.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15907&type=smp
Which Significant Factors Are Encouraging Growth In The Pulmonary Drug Delivery Devices Market?
The rising incidence of respiratory disorders is set to propel the expansion of the pulmonary drug delivery devices market moving forward. Respiratory disorders are defined as illnesses or conditions impacting the lungs and airways, thereby affecting human breathing. The growing prevalence of these disorders is attributed to various factors such as escalating air pollution levels, increased smoking rates, urbanization, climate change, and the aging population. Pulmonary drug delivery devices play a vital role in managing respiratory disorders by enabling the direct administration of medications to the lungs. As an illustration, in December 2023, a research study published by JAMA Network Open, a medical journal from the American Medical Association, projected that the worldwide cases of chronic obstructive pulmonary disease (COPD) could reach nearly 600 million by 2050, representing a 23% increase in prevalence. Consequently, the increasing prevalence of COPD is a key driver for the growth of the pulmonary drug delivery devices market.
How Does Segment Analysis Break Down The Pulmonary Drug Delivery Devices Market Structure?
The pulmonary drug delivery devices market covered in this report is segmented –
1) By Product Type: Dry Powder Inhalers, Metered Dose Inhalers, Nebulizers
2) By Application: Asthma, Cystic Fibrosis, Chronic Obstructive Pulmonary Disease, Other Applications
3) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, E-Commerce
Subsegments:
1) By Dry Powder Inhalers (DPIs): Single-Dose DPIs, Multi-Dose DPIs
2) By Metered Dose Inhalers (MDIs): CFC-Based MDIs, HFA-Based MDIs
3) By Nebulizers: Jet Nebulizers, Ultrasonic Nebulizers, Mesh Nebulizers
What Trends Are Impacting The Pulmonary Drug Delivery Devices Market?
Leading companies operating in the pulmonary drug delivery devices market are developing innovative products, such as small-volume nebulizers, to provide customers with more advanced features. A small-volume nebulizer (SVN) is a medical apparatus employed to administer liquid medication in the form of an aerosolized mist to patients with respiratory ailments like asthma, chronic obstructive pulmonary disease (COPD), or cystic fibrosis. For instance, in May 2024, Medline Industries LP, a US-based healthcare firm, introduced the Hudson RCI TurboMist small-volume nebulizer. This innovative device is designed to deliver medication treatments swiftly, in as little as three minutes. This advanced nebulizer can dispense 2.5 times more medication per minute compared to standard nebulizers, thereby decreasing treatment times by approximately 70%. This enhancement in medication delivery significantly shortens treatment durations, proving advantageous for healthcare providers by optimizing patient throughput and improving the patient experience by reducing the length of therapy sessions.
Who Are The Key Market Participants In The Pulmonary Drug Delivery Devices Market?
Major companies operating in the pulmonary drug delivery devices market are Medtronic plc, Air Liquide S.A., Becton Dickinson And Company, Koninklijke Philips N.V., Medline Industries Inc., ResMed Inc., Drägerwerk AG And Co. KGaA, Smiths Group plc, AptarGroup Inc., Chiesi Farmaceutici S.p.A., Teleflex Incorporated, Fisher And Paykel Healthcare Limited, Invacare Corporation, Vyaire Medical Inc., Inogen Inc., Drive DeVilbiss Healthcare Inc., Hovione, Hamilton Medical AG, GaleMed Corporation, Allied Healthcare Products Inc., Precision Medical Inc., Salter Labs Inc.
Access The Complete Pulmonary Drug Delivery Devices Market Report:
Which Area Represents The Largest Portion Of The Pulmonary Drug Delivery Devices Market?
North America was the largest region in the pulmonary drug delivery devices market in 2025. The regions covered in the pulmonary drug delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Customized Pulmonary Drug Delivery Devices Market Report for Deeper Competitive Insights
Browse Through More Reports Similar to the Global Pulmonary Drug Delivery Devices Market 2026, By The Business Research Company
Drug Delivery Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report
Drug Delivery Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report
Injectable Drug Delivery Devices Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
